Intellipharmaceutics International Inc. (IPCI)

[92662]

I think high 3's and then a selloff for profit and end up low 3's or high 2's since they don't have a partner and sales won't start until April 1, 2017. They will need capital and will draw on the shelf or get it from a partner. A number of the potential partners are gone. Once a partner is signed, patent received, NDA filed or another drug approved we will see higher and higher pricing, just a matter of time. Just my opinion.